BioXcel Therapeutics, Inc. (BTAI)
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Investigation
02/26/2021
Initial Lawsuit
02/26/2021
Lawsuit Progression
06/07/2021
Dismissal
07/30/2021
Investigation regarding AgEagle’s rumored partnership with Amazon and its alleged role in spreading the rumors.
02/18/2021
Bonitas research publishs a report alleging AgEagle was nothing more than a “pump and dump” built on ” fake Amazon partnership rumors.”
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$8.96 | $14.09 | $-5.13 | -36.41% |
Plaintiff brings this securities class action on behalf of persons or entities who purchased or otherwise acquired publicly traded AgEagle securities between September 3, 2019 and February 18, 2021, inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors that:
(1) AgEagle did not have a partnership with Amazon and in fact never had any relationship with Amazon;
(2) rather than correct the public’s understanding about a partnership with Amazon, defendants were actively contributing to the rumor that AgEagle had a partnership with Amazon; and
(3) as a result, defendants’ statements about AgEagle’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
06/07/2021
The court issued an order appointing the lead plaintiff and lead counsel.
On 07/30/2021, plaintiff voluntarily dismissed the complaint.
Lead Plaintiff has determined, following an investigation, not to file an amended complaint and hereby gives notice, by his undersigned counsel of record, that this action is voluntarily dismissed without prejudice pursuant to Fed. R. Civ. P. 41(a)(1)(A); and
Further, notice of this voluntary dismissal is not required under Fed. R. Civ. P. 23(e) because Lead Plaintiff has not settled any claim, nor does Lead Plaintiff seek to voluntarily dismiss the claims of any certified class or any class proposed to be certified for purposes of settlement.
Free File
Stipulation/Order of Dismissal
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.